Increased levels of endogenous HMGB1 have also been detected in neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and multiple sclerosis, contributing to chronic neurodegeneration and progression of neuroinflammation [73]. The gene discussed is HMGB1; the disease is early-onset autosomal dominant Alzheimer disease.